NM_005765.3:c.-35G>C

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2

The NM_005765.3(ATP6AP2):​c.-35G>C variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00196 in 1,162,744 control chromosomes in the GnomAD database, including 27 homozygotes. There are 622 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.0099 ( 18 hom., 325 hem., cov: 24)
Exomes 𝑓: 0.0011 ( 9 hom. 297 hem. )

Consequence

ATP6AP2
NM_005765.3 5_prime_UTR_premature_start_codon_gain

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: 0.00600

Publications

1 publications found
Variant links:
Genes affected
ATP6AP2 (HGNC:18305): (ATPase H+ transporting accessory protein 2) This gene encodes a protein that is associated with adenosine triphosphatases (ATPases). Proton-translocating ATPases have fundamental roles in energy conservation, secondary active transport, acidification of intracellular compartments, and cellular pH homeostasis. There are three classes of ATPases- F, P, and V. The vacuolar (V-type) ATPases have a transmembrane proton-conducting sector and an extramembrane catalytic sector. The encoded protein has been found associated with the transmembrane sector of the V-type ATPases. [provided by RefSeq, Jul 2008]
ATP6AP2 Gene-Disease associations (from GenCC):
  • ATP6AP2-related disorder
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • congenital disorder of glycosylation, type IIr
    Inheritance: XL Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • syndromic X-linked intellectual disability Hedera type
    Inheritance: XL Classification: STRONG, MODERATE, SUPPORTIVE, LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics, Genomics England PanelApp
  • X-linked parkinsonism-spasticity syndrome
    Inheritance: Unknown, XL Classification: MODERATE, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet, Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (REVEL=0.01).
BP6
Variant X-40581031-G-C is Benign according to our data. Variant chrX-40581031-G-C is described in ClinVar as Benign. ClinVar VariationId is 136464.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00994 (1126/113284) while in subpopulation AFR AF = 0.0342 (1072/31308). AF 95% confidence interval is 0.0325. There are 18 homozygotes in GnomAd4. There are 325 alleles in the male GnomAd4 subpopulation. Median coverage is 24. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 18 XL,AR,Unknown gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_005765.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATP6AP2
NM_005765.3
MANE Select
c.-35G>C
5_prime_UTR_premature_start_codon_gain
Exon 1 of 9NP_005756.2
ATP6AP2
NM_005765.3
MANE Select
c.-35G>C
5_prime_UTR
Exon 1 of 9NP_005756.2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATP6AP2
ENST00000636580.2
TSL:1 MANE Select
c.-35G>C
5_prime_UTR_premature_start_codon_gain
Exon 1 of 9ENSP00000490083.1O75787-1
ATP6AP2
ENST00000636580.2
TSL:1 MANE Select
c.-35G>C
5_prime_UTR
Exon 1 of 9ENSP00000490083.1O75787-1
ATP6AP2
ENST00000636639.1
TSL:1
n.-35G>C
5_prime_UTR_premature_start_codon_gain
Exon 1 of 10ENSP00000490382.1A0A1B0GV60

Frequencies

GnomAD3 genomes
AF:
0.00994
AC:
1125
AN:
113235
Hom.:
18
Cov.:
24
show subpopulations
Gnomad AFR
AF:
0.0343
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00331
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000938
Gnomad OTH
AF:
0.00851
GnomAD2 exomes
AF:
0.00237
AC:
245
AN:
103268
AF XY:
0.00149
show subpopulations
Gnomad AFR exome
AF:
0.0386
Gnomad AMR exome
AF:
0.00130
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000269
Gnomad OTH exome
AF:
0.000647
GnomAD4 exome
AF:
0.00110
AC:
1157
AN:
1049460
Hom.:
9
Cov.:
30
AF XY:
0.000867
AC XY:
297
AN XY:
342370
show subpopulations
African (AFR)
AF:
0.0393
AC:
975
AN:
24830
American (AMR)
AF:
0.00147
AC:
41
AN:
27853
Ashkenazi Jewish (ASJ)
AF:
0.0000539
AC:
1
AN:
18560
East Asian (EAS)
AF:
0.00
AC:
0
AN:
27074
South Asian (SAS)
AF:
0.000141
AC:
7
AN:
49787
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
35617
Middle Eastern (MID)
AF:
0.00112
AC:
4
AN:
3560
European-Non Finnish (NFE)
AF:
0.0000183
AC:
15
AN:
817979
Other (OTH)
AF:
0.00258
AC:
114
AN:
44200
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
43
86
130
173
216
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
36
72
108
144
180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00994
AC:
1126
AN:
113284
Hom.:
18
Cov.:
24
AF XY:
0.00917
AC XY:
325
AN XY:
35460
show subpopulations
African (AFR)
AF:
0.0342
AC:
1072
AN:
31308
American (AMR)
AF:
0.00330
AC:
36
AN:
10897
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2656
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3546
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2834
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6297
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
217
European-Non Finnish (NFE)
AF:
0.0000938
AC:
5
AN:
53301
Other (OTH)
AF:
0.00840
AC:
13
AN:
1547
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
40
81
121
162
202
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00543
Hom.:
22
Bravo
AF:
0.0121

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.49
CADD
Benign
7.7
DANN
Benign
0.84
PhyloP100
0.0060
PromoterAI
-0.044
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0
Mutation Taster
=300/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs111632930; hg19: chrX-40440283; API